Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Invesco India Pharma and Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Invesco | ICICI Pru |
| NAV | ₹10.7800 | ₹27.8400 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 2 months | 5.8 years |
| Expense ratio | 1.9% | 1.0% |
| Stars | Not rated | ★★★★★ |
| Growth Score | — | 79.20 |
Returns
| Invesco India Pharma and Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| 1 month | +19.78% | +11.58% |
| 3 months | — | +4.70% |
| 6 months | — | +8.33% |
| YTD | — | +2.02% |
| 1 year | — | +1.64% |
| 3 years (CAGR) | — | +16.92% |
| 5 years (CAGR) | — | +16.09% |
| 10 years (CAGR) | — | — |
| Since launch | +7.58% | +19.15% |
Risk
| Invesco India Pharma and Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| Volatility | — | 15.4% |
| Downside volatility | — | 9.7% |
| Sharpe | — | 0.68 |
| Sortino | — | 1.07 |
| Calmar | — | 1.18 |
| Return / risk | — | 1.10 |
| Deepest fall | −11.39% | −14.39% |
| Days to recover | 14 | 101 |
| Below its high | +0.00% | +0.00% |
Against benchmark
| Invesco India Pharma and Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| Alpha | — | +4.27% |
| Beta | — | 0.92 |
| R² | — | 92.0% |
| Up capture | — | 103.3% |
| Down capture | — | 80.8% |
| Tracking error | — | 4.6% |
| Information ratio | — | 0.83 |
| Treynor | — | 0.10 |
Consistency
| Invesco India Pharma and Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| Best 1-year | — | +57.85% |
| Middle 1-year | — | +14.06% |
| Worst 1-year | — | −9.72% |
| 1-year periods with a loss | — | 4.1% |
| Middle 3-year | — | +23.35% |
| Positive months | — | 61.1% |
| Best day | +3.62% | +4.49% |
| Worst day | −2.74% | −5.43% |
| Worst 5% day | −1.53% | −1.26% |
| Positive days | 48.9% | 54.8% |
| NAVs a year | 48 | 247 |
SIP of ₹10,000 a month
| Invesco India Pharma and Healthcare Fund | ICICI Prudential Business Cycle Fund | |
|---|---|---|
| 5-year XIRR | — | +15.82% |
| 5-year value | — | ₹8,98,335 |
| 3-year XIRR | — | +10.13% |
| 1-year XIRR | — | +10.49% |
Holdings overlap i
Overlap compares the shares two funds hold, so it needs at least two of these funds with shares in a loaded monthly filing.
- Invesco India Pharma and Healthcare Fund: no monthly portfolio filing from Invesco is loaded yet, so it is left out here.